HSE refuses to fund revolutionary cystic fibrosis drug
The HSE has flatly refused to provide funding for a revolutionary new drug to treat cystic fibrosis, thus effectively denying the possibility of greatly lengthened and much improved lifespan for thousands of sufferers. Orkambi, an …
